115 related articles for article (PubMed ID: 12387578)
1. Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease.
Kalela A; Koivu TA; Sisto T; Kanervisto J; Höyhtyä M; Sillanaukee P; Lehtimäki T; Nikkari ST
Scand J Clin Lab Invest; 2002; 62(5):337-42. PubMed ID: 12387578
[TBL] [Abstract][Full Text] [Related]
2. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Brunner S; Kim JO; Methe H
Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
[TBL] [Abstract][Full Text] [Related]
3. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
[TBL] [Abstract][Full Text] [Related]
4. Comparision of high sensitivity C-reactive protein and matrix metalloproteinase 9 in patients with unstable angina between with and without significant coronary artery plaques.
Wang LX; Lü SZ; Zhang WJ; Song XT; Chen H; Zhang LJ
Chin Med J (Engl); 2011 Jun; 124(11):1657-61. PubMed ID: 21740772
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
Opstad TB; Pettersen AA; Weiss TW; Akra S; Øvstebø R; Arnesen H; Seljeflot I
Clin Chim Acta; 2012 Jan; 413(1-2):113-20. PubMed ID: 21963461
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
[TBL] [Abstract][Full Text] [Related]
7. Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.
Jguirim-Souissi I; Jelassi A; Addad F; Hassine M; Najah M; Ben Hamda K; Maatouk F; Ben Farhat M; Bouslema A; Rouis M; Slimane MN
Am J Cardiol; 2007 Jul; 100(1):23-7. PubMed ID: 17599435
[TBL] [Abstract][Full Text] [Related]
8. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
Katerinis I; Nguyen QV; Magnin JL; Descombes E
Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
[TBL] [Abstract][Full Text] [Related]
9. Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease.
Fitzsimmons PJ; Forough R; Lawrence ME; Gantt DS; Rajab MH; Kim H; Weylie B; Spiekerman AM; Dehmer GJ
Atherosclerosis; 2007 Sep; 194(1):196-203. PubMed ID: 16942771
[TBL] [Abstract][Full Text] [Related]
10. Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.
Balogh E; Bereczky Z; Katona E; Koszegi Z; Edes I; Muszbek L; Czuriga I
Thromb Res; 2012 Feb; 129(2):133-8. PubMed ID: 21803402
[TBL] [Abstract][Full Text] [Related]
11. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis.
Alvarez B; Ruiz C; Chacón P; Alvarez-Sabin J; Matas M
J Vasc Surg; 2004 Sep; 40(3):469-75. PubMed ID: 15337875
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
13. Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome.
Yan JC; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Acta Pharmacol Sin; 2004 Feb; 25(2):251-6. PubMed ID: 14769218
[TBL] [Abstract][Full Text] [Related]
14. Supra-aortic extracranial artery atherosclerotic lesions in patients diagnosed for coronary artery disease: prevalence and predictors.
Przewłocki T; Kabłak-Ziembicka A; Kozanecki A; Musiałek P; Piskorz A; Rzeźnik D; Pieniazek P; Rubiś P; Tracz W
Kardiol Pol; 2009 Aug; 67(8A):985-91. PubMed ID: 19784903
[TBL] [Abstract][Full Text] [Related]
15. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
[TBL] [Abstract][Full Text] [Related]
16. [Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease].
Gao B; Li ZC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):536-9. PubMed ID: 15355616
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteases 2 and 9, Lp-PLA(2) and lipoprotein profile in coronary patients.
Muzzio ML; Miksztowicz V; Brites F; Aguilar D; Repetto EM; Wikinski R; Tavella M; Schreier L; Berg GA
Arch Med Res; 2009 Jan; 40(1):48-53. PubMed ID: 19064127
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.
Blankenberg S; Rupprecht HJ; Poirier O; Bickel C; Smieja M; Hafner G; Meyer J; Cambien F; Tiret L;
Circulation; 2003 Apr; 107(12):1579-85. PubMed ID: 12668489
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of circulating matrix metalloproteinase-9 are associated with a dysregulated cortisol rhythm--A case-control study of coronary artery disease.
Szymanowski A; Nijm J; Kristenson M; Jonasson L
Psychoneuroendocrinology; 2011 Jan; 36(1):139-43. PubMed ID: 20674181
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis.
Wang J; Warzecha D; Wilcken D; Wang XL
Clin Sci (Lond); 2001 Jul; 101(1):87-92. PubMed ID: 11410119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
